TMEM230 is a newly identified Parkinson's disease (PD) gene encoding a transmembrane protein whose cellular and pathogenic roles remain largely unknown. Here, we demonstrate that loss of TMEM230 disrupts retromer cargo CI-M6PR (cation-independent mannose 6-phosphate receptor) trafficking and autophagic cargo degradation rates. TMEM230 depletion further inhibits extracellular secretion of the autophagic cargo p62 and immature lysosomal hydrolases in Golgi-derived vesicles leading to their intracellular accumulation, and is specifically mediated by loss of the small GTPase Rab8a. Importantly, PDlinked TMEM230 variants also induce retromer mislocalization, defective cargo trafficking, and impaired autophagy. Finally, we show that knockdown of another PD gene, LRRK2, which phosphorylates Rab8a, similarly impairs retromer trafficking, secretory autophagy and Golgi-derived vesicle secretion, thus demonstrating converging roles of two PD genes TMEM230 and LRRK2 on Rab8a function, and suggesting that retromer and secretory dysfunction play an important role in PD pathogenesis.
Introduction
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder characterized by resting tremors, bradykinesia, rigidity, postural instability as well as additional prodromal non-motor symptoms. PD patients develop early degeneration of substantia nigra pars compacta (SNpc) and Lewy body pathology (1) . Previous pedigree studies and large-scale GWAS-study have identified multiple potential susceptibility genes and loci related to PD (2) (3) (4) . Although the precise pathogenic molecular mechanisms of PD remain under intense investigation, accumulating evidence suggests that oxidative stress and mitochondrial dysfunction, impaired autophagic-lysosomal pathways, and defective vesicle trafficking play important roles in PD pathogenesis (5) .
TMEM230 (Transmembrane Protein 230, also known as C20orf30) was recently identified as a novel PD gene in a large PD family of Northern European ancestry with 81 members (15 affected) and a mean disease onset of 65.5 years (6) . Genetic linkage analysis and whole exome sequencing identified R141L as the pathogenic variant in 4 affected individuals which was associated with an autosomal dominant mode of inheritance in this family. Additional PD-linked mutations (Y92C and *184Wext*5) were identified by DNA sequencing of 832 PD samples collected in North America, including 433 familial and 399 sporadic PD cases. Subsequently, an *184PGext*5 mutation in TMEM230 was identified in nine PD patients from seven families with PD in China. Interestingly, the *184PGext*5 mutation was associated with both autosomal dominant and autosomal recessive inheritance in these families (6) .
TMEM230 is a putative transmembrane protein with ubiquitous expression and no obvious sequence homology to any other known protein. Ectopically expressed TMEM230 localized with VMAT2-positive vesicles, VPS35-positive endosomes, Rab11-positive recycling endosomes, and Rab5-positive early endosomes, with predominant enrichment in STX-6-positive trans-Golgi network (TGN). Expression of PD-linked TMEM230 mutants led to a-synuclein accumulation and decreased motility of GFP-VAMP2-labelled vesicles. TMEM230 was also found in a-synuclein-positive Lewy bodies and Lewy neurites in the midbrain and neocortex sections from patients with sporadic PD and Dementia with Lewy bodies (DLB) (6) .
While the genetic evidence demonstrating TMEM230 as a causative gene for familial PD has been established (6) , its normal and pathological cellular functions remain to be elucidated. Here we show that loss of function of TMEM230 impairs secretory autophagy (exophagy), Golgi-derived vesicle secretion and retromer trafficking, which is mediated by loss of Rab8a. Importantly, we also demonstrate retromer and autophagic dysfunction upon expression of PD-linked TMEM230 variants and in PD TMEM230 mutant patient lymphoblastoid cell lines. Finally, we show that knockdown of another PD gene, LRRK2, which has previously been shown to phosphorylate Rab8a (7), similarly impairs secretory autophagy (exophagy) and Golgiderived vesicle secretion, thus demonstrating converging roles of two PD genes TMEM230 and LRRK2 on Rab8a function. Importantly, these results implicate retromer and secretory dysfunction in TMEM230 and LRRK2-mediated PD pathophysiology.
Results

PD-linked R141L TMEM230 variant impairs normal retromer trafficking
Previous immunostaining studies suggested that TMEM230 predominantly localized to the trans-Golgi network and partially co-localized with vacuolar protein sorting-35 (VPS35), a core component of the retromer complex (6) . The retromer mediates retrograde vesicular transport of transmembrane proteins from endosomes to the trans-Golgi network (TGN) and the plasma membrane (8) (9) (10) . To explore the cellular consequences of TMEM230 variants on the intracellular distribution of VPS35, we first expressed wild-type or PD-linked mutants (R141L or *184Wext*5) TMEM230 (Supplementary Material, Fig. S1 ) together with FLAG-VPS35 in COS-7 cells. Both wildtype TMEM230 and VPS35 showed cytoplasmic distribution with higher immunostaining intensity near the nucleus (Fig. 1A and B ). In contrast, the PD-linked R141L-TMEM230 mutant co-localized with VPS35 into a punctate cytoplasmic distribution. In addition, the PD-linked *184Wext*5-TMEM230 mutant also showed robust punctate distribution and co-localized with VPS35 ( Fig. 1A and  B) . These data indicate that PD-linked TMEM230 variants (R141L and *184Wext*5) contribute to altered intracellular distribution of the retromer component VPS35.
The best characterized retromer cargo is the cationindependent mannose 6-phosphate receptor (CI-M6PR) which binds newly synthesized lysosomal hydrolases in the transGolgi network (TGN) for delivery to pre-lysosomal compartments (8, 11) . Defective retromer function is associated with reduced CI-M6PR levels, leading to impaired retrieval of CI-M6PR from endosomes to the TGN and subsequent degradation of CI-M6PR in lysosomes (8, 12, 13) . To examine whether PD-linked TMEM230 variants alter CI-M6PR retromer cargo trafficking, we expressed wildtype or PD-linked R141L-TMEM230 mutant in HEK293-FT cells and examined CI-M6PR protein levels either at steady state or after Baf-A1 treatment to examine lysosomal flux. Baf-A1 acts by inhibiting vacuolar H þ ATPase (V-ATPase) which neutralizes lysosomal pH and therefore inhibits the activity of lysosomal hydrolases (14) . At steady state (untreated cells), we observed a significant decrease in CI-M6PR levels in the presence of mutant R141L-TMEM230, as compared to wildtype TMEM230 (Fig. 1C and D) . In contrast, R141L-TMEM230 did not disrupt the protein levels of VPS35 either at steady state or upon Baf-A1 treatment ( Fig. 1C and E) .
To further examine retromer dysfunction in the presence of TMEM230 PD-linked mutants, we tested human lymphoblastoid cell lines derived from PD patients with a heterozygous R141L mutation, as well as two healthy individuals from the same family, and a line derived from an unrelated individual carrying a heterozygous ALS (Amyotrophic Lateral Sclerosis)-linked SPG11 mutation. TMEM230 protein levels were significantly lower in one of the R141L mutant lines compared to healthy controls ( Fig. 1F and G) . In addition, CI-M6PR protein levels from the two PD TMEM230 mutant patient lines were significantly reduced compared to the lines derived from healthy family members, while the line from the unrelated individual carrying the heterozygous SPG11 mutation did not show a reduction in CI-M6PR ( Fig. 1F and H) . Taken together, these results suggest that the PD-linked R141L-TMEM230 mutation impairs retromer trafficking.
TMEM230 regulates autophagy-mediated clearance of p62 and a-synuclein
Increasing evidence suggests that impaired autophagylysosomal function plays a key role in the pathogenesis of PD (15) . Previously we found increased levels of intracellular aÀsynuclein upon expression of PD-associated TMEM230 mutants (6) . Since a-synuclein is predominantly degraded by the autophagy-lysosomal clearance pathway (16), we next tested whether endogenous TMEM230 regulates the autophagic pathway. For this, we first generated two stable HEK239-FT cell lines that either expressed scrambled-shRNAi or TMEM230-shRNAi (Supplementary Material, Fig. S2 ). Using carbonyl cyanide mchlorophenylhydrazone (CCCP), a mitochondrial uncoupler known to induce robust autophagic clearance of ubiquitinated substrates (17, 18) , we monitored CCCP-induced clearance of SQSTM1/p62, a-synuclein, and mitofusin 1 (Mfn1). Upon CCCPtreatment, protein levels of p62 and a-synuclein gradually declined in control Scr-RNAi cell line ( Fig. 2A-C) . However, upon TMEM230 RNAi depletion, the autophagic clearance rates of p62 and a-synuclein were significantly reduced ( Fig. 2A-C) . Importantly, the CCCP-induced clearance rate of Mfn1, a cargo ubiquitinated by activated Parkin and which undergoes proteasomal rather than autophagic degradation (17), was not altered by TMEM230 depletion ( Fig. 2A and D) . Interestingly, TMEM230 itself was also reduced upon CCCP treatment in Scr-RNAi cells ( Fig. 2A and E) . Taken together, these results demonstrate that TMEM230 depletion disrupts efficient CCCP-induced autophagic clearance of both p62 and a-synuclein.
SQSTM1/p62 and LC3-II are important for selective targeting of ubiquitinated proteins for lysosomal degradation and accumulate when autophagic flux is impaired (19) . To determine how PD-associated TMEM230 variants affect autophagy, we expressed PD-linked TMEM230 mutants (R141L, *184Wext*5 and Y92C) (Fig. 2F and Supplementary Material, Fig. S1 ) and examined p62 and LC3-II protein levels. In the presence of PD-associated TMEM230 mutants, intracellular levels of both p62 and LC3-II levels were increased, as compared with wildtype TMEM230 (Fig. 2G-I ), further suggesting that PD-associated TMEM230 mutants disrupt autophagy.
TMEM230 regulates retromer trafficking and secretory autophagy
Thus far, we have demonstrated that PD-associated TMEM230 variants disrupt both retromer trafficking and autophagy. These findings raise the question as to whether endogenous TMEM230 normally regulates these pathways. First, to examine endogenous TMEM230's role in retromer trafficking, we expressed either Scr-RNAi or TMEM230-RNAi in HEK293-FT cells for two days to knockdown TMEM230 levels (Fig. 3A) , and examined the levels of the retromer cargo CI-M6PR. Similar to what was observed upon expression of TMEM230 PD-linked R141L mutant (Fig. 1D) , RNAi knockdown of TMEM230 reduced steady state levels of CI-M6PR (Fig. 3A and B) , suggesting that TMEM230 normally regulates the retromer trafficking of CI-M6PR, and that the R141L mutation leads to partial TMEM230 loss of function.
Next, we examined endogenous TMEM230's role in autophagy by examining autophagic flux using Baf-A1 to inhibit lysosomal hydrolases. Importantly, TMEM230 knockdown by RNAi led to a significant accumulation of p62 and LC3-II upon Baf-A1 treatment (Fig. 3A,C and D) . Baf-A1 acts by inhibiting vacuolar Hþ ATPase (V-ATPase) in lysosomes and neutralizing lysosomal pH (14) , which induces lysosomal calcium release and the induction of various secretory trafficking events, including lysosomal exocytosis (20) , Golgi-derived vesicle secretion (21, 22) , and secretory autophagy (also known as exophagy) (23) (24) (25) (26) (27) (28) . To investigate whether TMEM230 depletion misregulates extracellular secretion of p62, we analysed p62 protein levels in the extracellular media fractions after Baf-A1 treatment. Interestingly, we found that Baf-A1 treatment in cells caused robust p62 secretion into extracellular media, but was dramatically impaired by TMEM230 depletion (Fig. 3I and J) , suggesting that TMEM230 dysfunction results in p62 accumulation due to defective secretory autophagy.
As our previous study showed predominant TMEM230-eGFP enrichment in the STX-6 positive TGN, we also investigated whether TMEM230 might regulate the secretion of Golgiderived vesicles. To test this, we examined the intracellular and secreted levels of immature lysosomal hydrolases which are cargo of Golgi-derived vesicles, and compared them to levels of mature lysosomal hydrolases which localize to lysosomes. In control cells, Baf-A1 led to the gradual extracellular 
Rab8a mediates TMEM230 regulation of retromer trafficking and the secretory pathway
Next, we asked how TMEM230 depletion might impair secretory autophagy and the secretion of Golgi-derived vesicles. The Rab family of small GTPases plays pivotal roles in various steps of vesicular trafficking in cells (29, 30) . Among these, Rab8a GTPase has been previously implicated in both secretory autophagy (exophagy) (23, 28) and trans-Golgi network to plasma membrane trafficking (31) . Given these previously studied cellular roles of Rab8a, we tested whether Rab8a might mediate the cellular defects we observed upon TMEM230 loss of function. Interestingly, TMEM230 depletion led to a significant reduction in Rab8a protein levels in cells (Fig. 4A ). In contrast, protein levels of Rab7a, a small GTPase implicated in endo-lysosomal trafficking, early-to-late Two days after transfection, cells were lysed with 2X SDS sample. Cell lysates were analysed with immunoblot analysis using indicated antibodies. Immunoblotting band intensities were normalized with tubulin band intensity, and compared to wild type TMEM230. Graphs show normalized band intensities of p62 (H) and LC3-II (I). Data represent mean 6 SEM, N > 5, two-tailed paired t-test, *¼P < 0.05; **¼P < 0.01; ***¼P < 0.001 compared with WT-TMEM230. endosomal maturation, endosomal positioning, and retromer trafficking, were not changed in TMEM230 depleted cells (Fig. 4A ).This finding raised the question of whether the secretory dysfunctions observed in TMEM230 knockdown cells might be due to functional loss of Rab8a.
To test this, we depleted endogenous Rab8a in HEK293-FT cells using RNAi. We found that Rab8a depletion accelerated Baf-A1 induced intracellular accumulation of p62 and LC3-II (Fig. 4B, D and E), concomitant with impaired extracellular secretion of the autophagic cargo p62 (Fig. 4J and K) . In addition, Rab8a depletion accelerated the intracellular accumulation of immature forms of lysosomal hydrolases (i-Cat-D and i-HEX-B) upon Baf-A1 treatment (Fig. 4B, F and H) , and inhibited their secretion into extracellular media ( Fig. 4J and L) . Thus, these results further corroborate the critical involvement of Rab8a in secretory autophagy and support an additional role for Rab8a in regulating the extracellular secretion of Golgi-derived vesicles, similar to what was observed upon TMEM230 loss of function.
To further confirm a role for Rab8a in secretory vesicle trafficking, we examined whether dominant negative Rab8a (T22N) expression had similar effects on the secretion of p62 and lysosomal hydrolases by expressing either GFP-tagged wild type Rab8a (WT-GFP-Rab8a) or GFP-tagged dominant negative T22N Rab8a (T22N-GFP-Rab8a) in HEK283-FT cells treated with or without Baf-A1. We found that consistent with the results from Rab8a depletion, dominant negative Rab8a T22N expression accelerated intracellular accumulation of both p62 and LC3-II Interestingly, we found that Rab8a depletion also had a small but significant effect on inhibiting the secretion of mature lysosomal hydrolases (Fig. 4J and M) , with little or no effect on their intracellular accumulation (Fig. 4B, G and I) , suggesting that Rab8a may additionally indirectly regulate lysosomal secretion. These results were also observed upon expression of dominant negative T22N-GFP-Rab8a (Supplementary Material, Fig. S3A 
, E, G, H, K and M).
Finally, as TMEM230 depletion and PD-linked mutants both disrupted steady-state levels of the retromer cargo CI-M6PR ( Figs 1D and 3B) , we wondered if Rab8a depletion might also mediate TMEM230-induced retromer dysfunction. Consistent with TMEM230 loss of function, we found that Rab8a depletion similarly reduced CI-M6PR protein levels at steady state and causes a trend towards increased accumulation of CI-M6PR upon treatment with Baf-A1 ( Fig. 4B and C) , indicative of abnormal trafficking of CI-M6PR retromer cargo into lysosomes. These results uncover a novel role for Rab8a in CI-M6PR retromer cargo trafficking, and further suggest that Rab8a mediates both retromer trafficking and secretory dysfunction upon TMEM230 loss of function.
Loss of PD-linked LRRK2 also disrupts retromer trafficking and the secretory pathway
Autosomal dominant mutations in leucine-rich repeat kinase (LRRK2) are one of the most common genetic causes of lateonset PD (32, 33) . However, the LRRK2 disease-initiating mechanism is still unclear due to the lack of understanding of bona fide LRRK2 kinase substrates. Recently, an unbiased phosphoproteomic study revealed that LRRK2 phosphorylates a subset of Rab GTPases (Rab3, Rab8a, Rab10 and Rab12), suggesting that LRRK2 might regulate Rab-mediated vesicle trafficking (7). In particular, LRRK2 was shown to interact with Rab8a, while the PD-associated LRRK2 variant (G2019S-LRRK2) increased Rab8a
Thr-72 phosphorylation which inhibited Rab8a's interaction with the Rab-GDI complex, resulting in an altered membranecytosol distribution of Rab8a (7) . Based on this recent study, we hypothesized that properly regulated kinase activation of LRRK2 might be critical for the proper activation cycle of Rab8a in cells, and that G2019S-LRRK2 might slow down the activation cycle of Rab8a by shifting the balance towards phosphorylated Rab8a accumulation in membrane compartments, leading to net inhibition of Rab8a-promoted vesicle trafficking. Supporting this idea, G2019S-LRRK2 has been reported to impair retromer trafficking (34) , resulting in reduced CI-M6PR protein levels, although the underlying mechanism remains elusive.
To further examine a role for endogenous LRRK2 in regulating retromer trafficking, we depleted endogenous LRRK2 with RNAi and examined CI-M6PR retromer cargo levels. Consistent with our observations with TMEM230 and Rab8a depletion ( Figs  3B and 4C) , knockdown of endogenous LRRK2 also reduced basal CI-M6PR levels, and induced progressive accumulation of the CI-M6PR protein upon Baf-A1 treatment (Fig. 5A and B) . We also confirmed that G2019S-LRRK2 expression reduced basal CI-M6PR protein levels, compared to wildtype LRRK2 (data not shown). Since both G2019S-LRRK2 expression and LRRK2-knockdown lead to reduced CI-M6PR protein levels in cells, these results suggest that the G2019S-LRRK2 variant may lead to loss of endogenous LRRK2 function resulting in defective retromer trafficking.
As depletion of endogenous TMEM230 disrupted both retromer trafficking as well as the secretion of autophagic cargo (p62) and Golgi-derived vesicle cargo (immature lysosomal hydrolases), we wondered if LRRK2 might also misregulate the secretory pathway. Although LRRK2 depletion did not disrupt Baf-A1 induced LC3-II accumulation (Fig. 5A and D) , we found that consistent with TMEM230 depletion, LRRK2 depletion induced a significant increase in Baf-A1 induced intracellular p62 accumulation ( Fig. 5A and C) , corresponding to a drastic inhibition of p62 secretion into extracellular media ( Fig. 5J and K) . Thus, endogenous LRRK2 may also regulate the efficient processing of secretory autophagy.
Consistent with TMEM230 depletion, LRRK2 knockdown also led to the accelerated intracellular accumulation of immature lysosomal hydrolases upon Baf-A1 treatment (Fig. 5A , E and G), corresponding to a decreased rate of extracellular secretion (Fig.  5J and L) . Furthermore, consistent with TMEM230 depletion, LRRK2 depletion did not alter intracellular levels of Baf-A1 treated mature forms of lysosomal hydrolases (Fig. 5A, F and H) or their secretion into extracellular media (Fig. 5J and M) . Thus, endogenous LRRK2 also regulates the extracellular secretion of Golgi-derived vesicles consistent with TMEM230 function. Taken together, these results demonstrate that both PDassociated genes TMEM230 and LRRK2 regulate efficient retromer trafficking, secretory autophagy, and Golgi-derived vesicle secretion.
Finally, we examined the interactions between TMEM230, LRRK2 and Rab8a levels. As TMEM230 depletion decreased Rab8a levels (Fig. 4A) , we examined if LRRK2 might similarly affect Rab8a levels. We found that while LRRK2 did not disrupt Rab8a levels at steady state, LRRK2 depletion led to the accelerated Baf-A1 accumulation of Rab8a in cells (Fig. 5A and  I ), suggesting that both TMEM230 and LRRK2 may disrupt Rab8a homeostasis. We also examined whether TMEM230 levels are altered by either Rab8a or LRRK2. Interestingly, we found that while LRRK2 depletion had no effect on TMEM230 levels (Supplementary Material, Fig. S4A ), Rab8a depletion led to a slight increase in TMEM230 levels (Supplementary Material, Fig. S4B ). Collectively, our results demonstrate a novel pathway for regulating cellular homeostasis in which LRRK2 and TMEM230 both regulate retromer trafficking and Rab8a-mediated secretory autophagy and extracellular secretion of Golgi-derived vesicles, and support a model in which PD-associated mutations in either protein lead to cellular dysfunction via retromer and secretory pathway dysfunction. 
Discussion
Mutations in TMEM230 were recently identified as a novel cause for familial PD (6), but TMEM230's normal cellular functions and the role of pathological PD-linked TMEM230 variants in PD pathogenesis have not been previously defined. In this study, we demonstrate novel roles for TMEM230 in retromer trafficking, secretory autophagy and Golgi-derived vesicle secretion, and show that PD-linked variants may contribute to retromer and autophagic pathway dysfunction. Endolysosomal dysfunction has previously been implicated in PD pathogenesis, and mutations in multiple PD genes including LRRK2, Parkin, ATP13A2 and VPS35 have been associated with defects in the endolysosomal pathway (15, 35) . In addition, defective autophagy has been linked to multiple PD genes (36) (37) (38) supported by mounting evidence demonstrating the importance of autophagy in PD (37, (39) (40) (41) (42) (43) (44) . However, the molecular details of endolysosomal and autophagic pathway dysfunction in PD pathogenesis have still not been fully elucidated.
Here, we report that the novel PD gene TMEM230 is critical for Rab8a-mediated secretory autophagy and Golgi-derived vesicle secretion. This novel functional connection between TMEM230 and Rab8a, a small GTPase implicated in secretory autophagy and TGN to plasma membrane trafficking, may thus be critical for further understanding the pathophysiological mechanisms in PD as previous studies have mainly focused on degradative autophagy, rather than on secretory autophagy.
Previous biochemical evidence implicate the involvement of Rab8a in the pathogenesis of PD. Rab8a is known to interact with the C-terminal region of a-synuclein (45) . LRRK2, the most common late onset familial PD gene, interacts with and phosphorylates Rab8a (7) . Furthermore, another recent phosphoproteomic study also revealed possible interactions between Rab8a and the PD-gene PINK1, as the most PINK1-responsive phospho-peptides included equivalent pSer111 phosphopeptides from Rab8A, Rab8B and Rab13, although these Rab proteins were not directly phosphorylated by PINK1 (46) . In rat primary neurons overexpressing a-synuclein, over-expression of Rab8a has also been reported to rescue cell death (47) . Moreover, overexpression of Rab8a, along with other Rab GTPases promotes the secretion of a-synuclein through secretory autophagy (25) , which may contribute to its cell-to-cell propagation in addition to other secretory pathways including exosome secretion (48) (49) (50) , conventional secretion from the Golgi (51), and brefeldin-Ainsensitive non-conventional secretion (52) . Interestingly, mutations in a-synuclein, LRRK2, and TMEM230, which are all functionally linked to Rab8a, cause a-synuclein-positive Lewy-body formation (6, (53) (54) (55) . Although secretory autophagy is largely unexplored in the PD-field, our work suggests that it may be a new area to investigate further for its relevance to PD pathogenesis.
TMEM230 predominantly localizes to the trans-Golgi network, endosome structures and synaptic vesicles (6), suggesting a possible role in the trafficking of these organelles. Indeed, Rab8a also promotes membrane traffic from the TGN to the plasma membrane, without affecting ER to Golgi transport (31) . Here we demonstrate that in addition to regulating secretory autophagy, TMEM230 also regulates Golgi-derived vesicle secretion of immature lysosomal hydrolases. Thus, we propose that TMEM230 depletion leads to Rab8a loss of function, resulting in defects in both secretory autophagy and Golgi-derived vesicle secretion.
LRRK2 has also previously been implicated in the regulation of the autophagy-lysosomal pathway, as LRRK2 knockout mice display striking accumulation and aggregation of the autophagic cargo p62, a-synuclein and ubiquitinated proteins at 20 months of age (42, 56) . Although disruption of protein degradation contributes to these defects, impaired secretory autophagy may further exacerbate the accumulation of these proteins. Here, we demonstrate that knockdown of endogenous LRRK2 impairs secretory autophagy, evidenced by hampered p62 secretion into extracellular media, suggesting that dysfunctional secretory autophagy may further contribute to protein accumulation in LRRK2 knockout mice. Previously, Beilina et al. reported that LRRK2 promotes Golgi-derived vesicle clearance through the degradative autophagy-lysosomal pathway (57) . Here we show that LRRK2 knockdown also inhibits Golgiderived vesicle secretion into extracellular media, providing another mechanism for how LRRK2 may promote Golgi-derived vesicle turnover.
Another key finding from this study is that TMEM230 contributes to the regulation of retromer trafficking. The retromer complex mediates endosome to trans-Golgi retrieval of CI-M6PR and other retromer cargo receptors (8, 12, 13, 58) . Dysfunctional retromer trafficking is known to cause abnormal flow of retromer cargo to the lysosome and abnormal lysosomal degradation (8) . Due to the increased lysosomal turnover of CI-M6PR in dysfunctional retromer trafficking, protein levels of CI-M6PR, the best characterized retromer cargo, are reduced at steady state. Moreover, mutations in the retromer component VPS35 have been linked to PD (59, 60) and reduced levels of cellular CI-M6PR have been reported in studies of PD genes including VPS35 (13, 41) , LRRK2 (34), Rab7L1 (61) , and Parkin (62), highlighting retromer dysfunction in PD pathogenesis (63) . In the present study, we found that the distribution of the retromer complex component VPS35 was disrupted in cells expressing PD-linked TME230 mutants (R141L and *184Wext*5), and that cellular levels of the retromer cargo CI-M6PR were reduced upon TMEM230 knockdown or R141L-TMEM230 expression. We also demonstrated that Rab8a is necessary for maintenance of normal CI-M6PR protein levels. Although further studies will be required to elucidate the molecular mechanism by which the loss of functions of TMEM230 and LRRK2 lead to reduced CI-M6PR protein levels, our data suggest that reduced Rab8a protein levels in TMEM230 knockdown cells, and altered Rab8a phosphorylation (or activation cycling) in LRRK2 knockdown cells may contribute at least in part to retromer dysfunction.
In summary, our study demonstrates a novel role for TMEM230 in regulating both retromer trafficking and the secretory pathway. Thus, it will be of interest to further investigate the mechanistic interplay between these two closely-related pathways in the pathogenesis of PD.
Materials and Methods
Antibodies and chemicals
The following antibodies were used in immunoblot analysis or immunostaining: anti-GFP (Cell Signaling, #2956), anti-FLAG (Sigma, #F7425), anti-TMEM230 (Origene, #TA504888), anti-CI-M6PR (Abcam, #ab124767E9644), anti-VPS35 (SantaCruz, #sc-374372), anti-tubulin (Sigma #T5168), anti-p62 (Sigma, #P0067), anti-a-synuclein (Santa Cruz #sc-7011-R), anti-Mfn1 (Cell Signaling, #13196), anti-LC3 (Cell Signaling, #3868), anticathepsin-D (Santa Cruz, #sc-6478), anti-HEX-B (Santa Cruz, #sc-376781), anti-Rab8a (Proteintech, #55296-1-AP), anti-Rab7a (Sigma, #R4779), anti-LRRK2 (NeuroMab, #75-253). Bafilomycin-A1 (Baf-A1) and Carbonyl cyanide m-chlorophenylhydrazone (CCCP) were purchased from Cayman chemicals. Other chemicals were purchased from Sigma, unless otherwise stated.
Plasmids
Tag-free TMEM230 expression vectors are previously described (6) . FLAG-VPS35 was a generous gift from Dr. Fumio Kishi (Kawasaki Medical School, Japan) (58) . The following lentiviral RNAi were purchased from GE-healthcare Life Sciences: TMEM230-RNAi (TRCN0000129581 (target sequence-5'-CCAGTGCTGATCATTGGCATT-3') and TRCN0000131231 (target sequence-5'-GACGATGGCTACATTGACCTT-3')), Rab8a-RNAi (TRCN0000048215 (target sequence-5'-CGAGAAGTCCTT CGACAACAT-3')), LRRK2-RNAi (TRCN0000021461 (target sequence-5'-GCCAGAGGAAATGTCATTTAT-3')). As a control, pLKO.1 with a nontargeting shRNA insert (5'-CCT AAG GTT AAG TCG CCC TCG CTC GAG CGA GGG CGA CTT AAC CTT AGG-3') was used. pGFP-Rab8A (Addgene Plasmid #24898) and pGFPRab8A-[T22N] (Addgene Plasmid #24899) were gifts from Dr. Maxence Nachury (Stanford University School of Medicine, CA).
Cell culture and transfection
Human embryonic kidney (HEK) cell line 293FT (Life Technologies) and African green monkey kidney fibroblast (COS-7) cells were maintained in Dulbecco's modified Eagle's Medium (DMEM) supplemented with 10% FBS (Life Technologies), 100 U/ml penicillin, and 100 lg/ml streptomycin at 37 C with 5% CO 2 incubation. Cells were plated one day prior to transfection in 12-well plates (Corning) at a density of approximately 125,000 cells per 12-well. Transfections were performed with Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommended protocol. Human lymphoblastoid cell lines were maintained in RPMI-1640 supplemented with 10% FBS, 100 U/ml penicillin, and 100 lg/ml streptomycin at 37 C with 5% CO 2 incubation.
Lentivirus preparation and generation of HEK293-FT cells expressing either TMEM230-RNAi or Scr-RNAi
For the production of lentiviral vectors, a 15 cm tissue culture dish containing 70% confluent HEK293FT cells was transfected with 10 lg of transfer vector (TMEM230-RNAi in pLKO.1 (TRCN0000131231) or control Scr-RNAi in pLKO.1), 9 lg psPAX2, and 1 lg VSVG using Lipofectamine2000 according to manufacturer's protocol for 16-18 h. The medium was then replaced into DMEM containing 10% fetal bovine serum and 1% Pen/Strep (Invitrogen). The virus was harvested 2 days post-transfection. The collected supernatant containing the virus was briefly spun at 1000 rpm and filtered through a 0.45 lm filter. The resulting virus mixture was concentrated at 80X with LentiXconcentrator reagent (Clontech), according to the manufacturer's protocol. The pellet containing the virus was resuspended with DMEM medium (Invitrogen) and frozen for future use. For the generation of stable HEK293-FT cell line expressing RNAi constructs, HEK293-FT cells in 6-well plates were infected with 1.5 ll of viral resuspension. HEK293-FT cells expressing either TMEM230-RNAi or Scr-RNAi were selected using puromycin (2 lg/mL).
Preparations of extracellular media fraction and cell lysates fraction
Transfected HEK293-FT cells in 12-wells were left untreated or treated with Baf-A1 (300 nM) for the indicated times at 37 C with 5% CO 2 incubation. Cells were then chilled on ice for 5 min. 0.9 ml of extracellular media samples from each 12-well were transferred to 1.5 ml tubues, and spun for 15 min at 550Xg in 4 C to remove cell debris. Subsequently 0.75 ml from the cleared media were transferred to new 1.5 ml tubes, and then the media samples were spun for 30 min at 2500Xg in 4 C. After the centrifugation, 0.5 ml of extracellular media samples were transferred to fresh 1.5 ml tubes for immunoblot analysis. For immunoblot analysis of extracellular media samples, 100 ll of cleared extracellular media samples from 2500xg spin were mixed with 100 ll of 4X SDS sample buffer (200 mM Tris-Cl (pH 6.8), 8% (w/v) SDS, 0.1% (w/v) bromophenol blue, 40% (v/v) glycerol, 400 mM DTT (dithiothreitol)) and boiled for 10 min. For the preparation of cell lysate fraction, cells on culture plates were washed once with PBS and lysed with 300 ml of 2X SDS-sample buffer.
Immunoblotting
Protein samples were subjected to SDS-PAGE. Proteins were then transferred to polyvinylidene fluoride (PVDF) or nitrocellulose membranes using Trans-Blot Turbo Transfer system (BioRad). The membranes were incubated overnight with the indicated primary antibodies. All primary antibodies were diluted in an antibody dilution buffer (25 mM Tris, 0.15 M NaCl, 0.05% Tween-20, 5% BSA, 0.05% sodium azide). Primary antibodies were visualized using the appropriate horseradish peroxidase conjugated secondary antibody (anti-mouse (Jackson immunoresearch lab, #115-035-146), anti-rabbit (Jackson immunoresearch lab, #111-035-144) anti-goat (Jackson immunoresearch lab, #805-035-180) and SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific, #34096). Blots were imaged on the ChemiDoc MP System (Bio-Rad) with a 16-bit CCD camera. The signal accumulation mode was used to acquire images at progressively longer exposure times. This allowed for acquisition of western blot images with band intensities within the linear range of the system. Quantification of protein levels was done using Bio-Rad ImageLab software and ImageJ (NIH) using non-saturated raw image files. Data were normalized to tubulin and expressed relative to control levels as indicated.
Immunostaining and imaging
COS-7 cells grown on cover glass were co-transfected with TMEM230 expression vectors and FLAG-VPS35. One day after transfection, COS-7 cells were fixed with 4% formaldehyde in PBS for 10 min. After fixation, cells were washed three times for 30 min at room temperature, and incubated with primary antibodies (rabbit anti-FLAG and mouse anti-TMEM230 antibody) in GDB buffer (30 mM phosphate buffer, pH 7.4, containing 0.1% gelatin, 0.3% Triton X-100, and 0.45 M NaCl) overnight at 4 C.
Cells were then washed three times in PBS for 30 min at room temperature and incubated with secondary antibody conjugated to Alexa-488 and Alexa-568 in GDB for 1 hr at room temperature and washed three times in PBS for 30 min. Images were taken with a Leica epifluorescence microscope with 40x air objective.
Statistics
All values in figures and text refer to mean 6 SEM unless otherwise stated. N refers to the number of independent experiments unless otherwise indicated. Statistics and graphing were performed using Prism (GraphPad) software. Statistical analysis of data was performed with two-tailed paired t-test unless otherwise indicated.
Supplementary Material
Supplementary Material is available at HMG online.
